Recap: Evoke Pharma Q4 Earnings

Evoke Pharma EVOK reported its Q4 earnings results on Thursday, March 14, 2024 at 04:10 PM.

Here's what investors need to know about the announcement.

Evoke Pharma missed estimated earnings by -18.0%, reporting an EPS of $-0.59 versus an estimate of $-0.5.

Revenue was up $880 thousand from the same period last year.

Last quarter the company beat on EPS by $0.11 which was followed by a 2.0% drop in the share price the next day.

Here's a look at Evoke Pharma's past performance:

Quarter	Q3 2023	Q2 2023	Q1 2023	Q4 2022
EPS Estimate	-0.62	-0.73	-0.58	-0.53
EPS Actual	-0.51	-0.56	-0.67	-0.54
Revenue Estimate	1.26M	1.10M	1.00M	890K
Revenue Actual	1.56M	1.13M	810K	796K

To track all earnings releases for Evoke Pharma visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar